<ARTICLE> 5 <LEGEND> FINANCIAL DATA SCHEDULE (RESTATED AS TO YEARS 1995 AND 1996). THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE COMPANY'S 1997 ANNUAL REPORT TO SHAREHOLDERS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <RESTATED> <CIK> 0000054381 <NAME> KAMAN CORPORATION <MULTIPLIER> 1,000 <PERIOD-TYPE> YEAR YEAR YEAR <FISCAL-YEAR-END> DEC-31-1997 DEC-31-1996 DEC-31-1995 <PERIOD-START> JAN-01-1997 JAN-01-1996 JAN-01-1995 <PERIOD-END> DEC-31-1997 DEC-31-1996 DEC-31-1995 <CASH> 109,974 <F1> 5,445 4,078 <SECURITIES> 0 0 0 <RECEIVABLES> 194,981 188,090 180,167 <ALLOWANCES> (3,827) (2,574) (2,289) <INVENTORY> 199,485 213,468 192,734 <CURRENT-ASSETS> 535,304 434,131 404,864 <PP&E> 153,146 191,323 189,317 <DEPRECIATION> (95,521) (114,930) (106,263) <TOTAL-ASSETS> 598,161 521,736 500,069 <CURRENT-LIABILITIES> 259,525 195,638 206,273 <BONDS> 29,867 83,940 66,386 <PREFERRED-MANDATORY> 0 0 0 <PREFERRED> 37,691 57,167 57,167 <COMMON> 20,604 18,743 18,456 <OTHER-SE> 231,715 152,220 138,660 <TOTAL-LIABILITY-AND-EQUITY> 598,161 521,736 500,069 <SALES> 1,043,365 948,106 896,398 <TOTAL-REVENUES> 1,044,815 953,654 899,476 <CGS> 787,971 708,505 666,761 <TOTAL-COSTS> 996,734 902,252 857,365 <OTHER-EXPENSES> (80,117) <F2> 702 546 <LOSS-PROVISION> 0 0 0 <INTEREST-EXPENSE> 7,894 10,023 8,834 <INCOME-PRETAX> 120,304 40,677 32,731 <INCOME-TAX> 49,800 17,100 13,129 <INCOME-CONTINUING> 70,504 23,577 19,602 <DISCONTINUED> 0 0 0 <EXTRAORDINARY> 0 0 0 <CHANGES> 0 0 0 <NET-INCOME> 70,504 23,577 19,602 <EPS-PRIMARY> 3.53 1.07 .87 <EPS-DILUTED> 2.86 1.00 .85 <FN> <F1> Includes $105,100 in an overnight repurchase agreement. This excess cash is the result of the sale of Kaman Sciences Corporation on December 30, 1997. <F2> Includes net gain on sale of businesses of $80,351. </FN>